Dr. Spiridonidis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8100 Ravines Edge Ct
Suite 100
Columbus, OH 43235Phone+1 614-846-0044Fax+1 614-846-3464
Education & Training
- Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 1984 - 1986
- University at BuffaloResidency, Internal Medicine, 1981 - 1984
- Aristotle University of Thessaloniki School of MedicineClass of 1978
Publications & Presentations
PubMed
- 3 citationsPhase II study of gemcitabine and cisplatin in patients with previously untreated extensive stage small cell lung cancer: Southwest Oncology Group Study 9718.Paul J. Hesketh, Kari Chansky, Valerie Israel, Richard Grapski, Tarek Mekhail
Journal of Thoracic Oncology. 2007-05-01 - 4 citationsPhase I Study of Doxil® and Vinorelbine in Patients with Advanced MalignanciesLeslie R. Laufman, C. Harris Spiridonidis, Jacqueline J. Jones, Virginia Rhodes, Karen Rossi
Cancer Investigation. 2004-08-18 - Evaluating the effectiveness of epoetin alfa in community oncology practices.C. Harris Spiridonidis, K. Brinkmannb, M. Fridman, Sanjay Gupta, Rima E. Tannous
Hematology. 2003-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: